DCF — UT HEALTH EAST TEXAS SPECIALTY HOSPI
Enterprise Value: $-27.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-27.2M
Enterprise Value
$-8.4M
PV of Cash Flows
$-18.8M
PV of Terminal Value
$-30.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $10.1M | $-1.8M | -18.0% | $-2.2M | $-2.0M |
| Year 2 | $10.4M | $-1.8M | -17.0% | $-2.2M | $-1.8M |
| Year 3 | $10.7M | $-1.7M | -16.0% | $-2.2M | $-1.6M |
| Year 4 | $11.1M | $-1.7M | -15.0% | $-2.2M | $-1.5M |
| Year 5 | $11.4M | $-1.7M | -15.0% | $-2.2M | $-1.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-27.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$9.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18452971379187635
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5